【Omron】Completed Share Buyback｜Results as of June 2026

Summary of the Buyback

Omron Healthcare conducted a public purchase of the target company's shares from May 19 to June 15, 2026, acquiring all 17,567,455 shares tendered. The purchase price was 1,110 yen per share, resulting in an increase in the voting rights ratio from 14.64% to 95.88%, acquiring a majority of shares. As a result, the target company is expected to proceed with procedures for delisting from the stock exchange.

Future Policy and Outlook

Following the completion of the buyback, Omron plans to acquire all shares of the target company and proceed with the delisting process. Specific procedures and schedules will be announced after consultations with the target company. This may lead to changes in the target company's business operations and stock liquidity.